Kopra Bio engineers viruses to teach the immune system to target and kill cancer, starting with glioblastoma, the most aggressive brain cancer. Using UCSF-developed technology, they achieve survival improvements from 0% with standard treatments to 90% in preclinical models.

We designed Kopra Bio’s landing page to communicate the life-saving potential of their therapies, the breakthrough science behind their platform, and the promise of next-generation cancer treatments.

Showcase your biotech innovation and attract partners, investors, and collaborators, book a call to bring your landing page to life.